A landmark study of gender medicine is caught in an ethics row

ONE REASON that transgender medicine is such a fraught subject is that there’s little proof behind the arguments. When Hilary Cass, a British paediatrician, reviewed the sphere for an influential report revealed in 2024, she famous that a lot of the science underlying the prescription of puberty blockers and cross-sex hormones to youngsters (an strategy known as “gender-affirming care”) was “remarkably weak”.